CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2024; 34(04): 714-725
DOI: 10.1055/s-0044-1785210
Review Article

COVID-19 Vaccines: A Radiological Review of the Good, the Bad, and the Ugly

1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Mohammad Sharoon Ansari
1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Pramod Kumar Singh
1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Sankha Shubhra Chakrabarti
2   Department of Geriatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
› Author Affiliations
Funding None.

Abstract

The World Health Organization has declared “with great hope” an end to COVID-19 as a public health emergency. The vaccination drive that started in December 2020 played a crucial role in controlling the pandemic. However, the pace at which COVID-19 vaccines were developed and deployed for general population use led to vaccine hesitancy, largely owing to concerns regarding the safety and efficacy of the vaccines. Radiology has been instrumental in demonstrating the extent of pulmonary involvement and identification of the complications of COVID-19, and the same holds true for vaccine-related complications. This review summarizes the existing body of radiological literature regarding the efficacy, adverse events, and imaging pitfalls that accompany the global rollout of various COVID-19 vaccines.



Publication History

Article published online:
21 April 2024

© 2024. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 MacDonald NE. SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine 2015; 33 (34) 4161-4164
  • 2 Thanh Le T, Andreadakis Z, Kumar A. et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov 2020; 19 (05) 305-306
  • 3 Wibawa T. COVID-19 vaccine research and development: ethical issues. Trop Med Int Health 2021; 26 (01) 14-19
  • 4 Kumar I, Verma A, Dangwal J, Singh PK, Chandra Shukla R, Chakravarty J. Magnetic resonance imaging spectrum of COVID-associated rhino-orbital-cerebral mucormycosis and assessment of anatomical severity. Neuroradiol J 2023; 36 (04) 404-413
  • 5 Borghesi A, Maroldi R. COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression. Radiol Med (Torino) 2020; 125 (05) 509-513
  • 6 Li K, Fang Y, Li W. et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol 2020; 30 (08) 4407-4416
  • 7 Yang R, Li X, Liu H. et al. Chest CT severity score: an imaging tool for assessing severe COVID-19. Radiol Cardiothorac Imaging 2020; 2 (02) e200047
  • 8 Verma A, Kumar I, Singh PK. et al. Initial comparative analysis of pulmonary involvement on HRCT between vaccinated and non-vaccinated subjects of COVID-19. Eur Radiol 2022; 32 (06) 4275-4283
  • 9 Lee JE, Hwang M, Kim YH. et al. Imaging and clinical features of COVID-19 breakthrough infections: a multicenter study. Radiology 2022; 303 (03) 682-692
  • 10 Vicini S, Bellini D, Iannarelli A. et al. Pneumonia frequency and severity in patients with symptomatic COVID-19: impact of mRNA and adenovirus vector vaccines. AJR Am J Roentgenol 2022; 219 (05) 752-761
  • 11 Hanafi M, Maryetty IP. , Widiastuti Chest imaging of COVID-19 patients amongst diverse vaccination status: a comparative study using Brixia score. GSC Advanced Research and Reviews 2022; 11 (02) 045-049
  • 12 Borghesi A, Zigliani A, Masciullo R. et al. Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients. Radiol Med (Torino) 2020; 125 (05) 461-464
  • 13 Rahman MT, Islam MI, Nahar NU, Ibrahim M, Zubery H, Shirin M. HRCT evaluation of post vaccinated RT-PCR positive COVID-19 patients at a dedicated COVID-19 hospital. European Journal of Clinical Medicine 2022; 3 (03) 14-17
  • 14 Lakhia RT, Trivedi JR. The CT scan lung severity score and vaccination status in COVID-19 patients during the second wave in India: perspective of an independent radiology practice. medRxiv 2021.07.15.21260597
  • 15 Granata V, Fusco R, Villanacci A. et al. Imaging Severity COVID-19 assessment in vaccinated and unvaccinated patients: comparison of the different variants in a high volume Italian Reference Center. J Pers Med 2022; 12 (06) 955
  • 16 Gurumurthy B, Das SK, Shetty S, Veerabhadrappa RC, Kosinepalli SS, Dharamaraju SH. CT severity score: an imaging biomarker to estimate the severity of COVID-19 pneumonia in vaccinated and non-vaccinated population. Egypt J Radiol Nucl Med 2022; 53 (01) 88
  • 17 Dubey R, Sen KK, Mitra A, Sethi HS, Arora R, Goyal M. Correlation of radiological findings on high-resolution computed tomography chest in vaccinated and unvaccinated COVID-19 patients from Eastern India. Indian J Respir Care 2022; 11: 124-127
  • 18 Su JR, McNeil MM, Welsh KJ. et al. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018. Vaccine 2021; 39 (05) 839-845
  • 19 Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation 2021; 144 (06) 471-484
  • 20 Gargano JW, Wallace M, Hadler SC. et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices: United States, June 2021. MMWR Morb Mortal Wkly Rep 2021; 70 (27) 977-982
  • 21 Friedrich MG, Sechtem U, Schulz-Menger J. et al; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009; 53 (17) 1475-1487
  • 22 Fronza M, Thavendiranathan P, Chan V. et al. Myocardial injury pattern at MRI in COVID-19 vaccine-associated myocarditis. Radiology 2022; 304 (03) 553-562
  • 23 Singh R, Chakrabarti SS, Gambhir IS. et al. Acute cardiac events after ChAdOx1 nCoV-19 corona virus vaccine: report of three cases. Am J Ther 2022; 29 (05) e579-e585
  • 24 Patel YR, Shah NR, Lombardi K. et al. Cardiac MRI findings in male patients with acute myocarditis in the presence or absence of COVID-19 vaccination. Radiol Cardiothorac Imaging 2022; 4 (03) e220008
  • 25 Sanchez Tijmes F, Zamorano A, Thavendiranathan P, Hanneman K. Imaging of myocarditis following mRNA COVID-19 booster vaccination. Radiol Cardiothorac Imaging 2022; 4 (02) e220019
  • 26 Dionne A, Sperotto F, Chamberlain S. et al. Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol 2021; 6 (12) 1446-1450
  • 27 Sung JG, Sobieszczyk PS, Bhatt DL. Acute myocardial infarction within 24 hours after COVID-19 vaccination. Am J Cardiol 2021; 156: 129-131
  • 28 Tajstra M, Jaroszewicz J, Gąsior M. Acute coronary tree thrombosis after vaccination for COVID-19. JACC Cardiovasc Interv 2021; 14 (09) e103-e104
  • 29 Özdemir İH, Özlek B, Özen MB, Gündüz R, Bayturan Ö. Type 1 Kounis syndrome induced by inactivated SARS-COV-2 Vaccine. J Emerg Med 2021; 61 (04) e71-e76
  • 30 Showkathali R, Yalamanchi R, Narra L. et al. Coronary thrombo-embolic events after Covid-19 vaccination: a single centre study. Indian Heart J 2022; 74 (02) 131-134
  • 31 Ifeanyi N, Chinenye N, Oladiran O, David E, Mmonu C, Ogbonna-Nwosu C. Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up. J Community Hosp Intern Med Perspect 2021; 11 (06) 877-879
  • 32 Al-Maqbali JS, Al Rasbi S, Kashoub MS. et al. A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. Am J Case Rep 2021; 22: e932946
  • 33 Wiest NE, Johns GS, Edwards E. A case of acute pulmonary embolus after mRNA SARS-CoV-2 immunization. Vaccines (Basel) 2021; 9 (08) 903
  • 34 Borisoff BD, Bohn KD, Sager J, Gracious BL. Unprovoked submassive saddle pulmonary embolism in an adult male after Pfizer COVID-19 vaccination. Cureus 2022; 14 (08) e27717
  • 35 Ogunkoya JO, Ogunmola MI, Ogunlade AF, Ladele AE. COVID-19 vaccination associated bilateral pulmonary embolism: cause or coincidence. Case Rep Pulmonol 2022; 2022: 9596285
  • 36 Warkentin TE, Cuker A. COVID-19: Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT). Waltham, MA: UpToDate; 2021
  • 37 Herrera-Comoglio R, Lane S. Vaccine-induced immune thrombocytopenia and thrombosis after the Sputnik V vaccine. N Engl J Med 2022; 387 (15) 1431-1432
  • 38 Rogers P, Walker I, Yeung J. et al; RADIANT Group. Thrombus distribution in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. Radiology 2022; 305 (03) 590-596
  • 39 Vierstraete M, Sabbe T. Aortic thrombosis and acute limb ischemia after ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccination: a case of vaccine-induced thrombocytopenia and thrombosis (VITT). Acta Chir Belg 2023; 123 (03) 329-332
  • 40 Gilio M, De Stefano G. Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine. Intern Emerg Med 2022; 17 (04) 1239-1241
  • 41 Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci 2022; 43 (01) 3-40
  • 42 Sriwastava S, Shrestha AK, Khalid SH, Colantonio MA, Nwafor D, Srivastava S. Spectrum of neuroimaging findings in post-COVID-19 vaccination: a case series and review of literature. Neurol Int 2021; 13 (04) 622-639
  • 43 Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus 2021; 13 (02) e13426
  • 44 Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep 2021; 14 (04) e242956
  • 45 Azam S, Khalil A, Taha A. Guillain-Barré syndrome in a 67-year-old male post COVID-19 vaccination (Astra Zeneca). Am J Med Case Rep 2021; 9: 424-427
  • 46 Maramattom BV, Krishnan P, Paul R. et al. Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 vaccine. Ann Neurol 2021; 90 (02) 312-314
  • 47 Rossetti A, Gheihman G, O'Hare M, Kosowsky JM. Guillain-Barré syndrome presenting as facial diplegia after COVID-19 vaccination: a case report. J Emerg Med 2021; 61 (06) e141-e145
  • 48 Prasad A, Hurlburt G, Podury S, Tandon M, Kingree S, Sriwastava S. A novel case of bifacial diplegia variant of Guillain-Barré syndrome following Janssen COVID-19 vaccination. Neurol Int 2021; 13 (03) 404-409
  • 49 Bonifacio GB, Patel D, Cook S. et al. Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine. J Neurol Neurosurg Psychiatry 2022; 93 (03) 341-342
  • 50 Keir G, Maria NI, Kirsch CFE. Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Top Magn Reson Imaging 2021; 30 (03) 133-137
  • 51 Queler SC, Towbin AJ, Milani C, Whang J, Sneag DB. Parsonage-Turner syndrome following COVID-19 vaccination: MR neurography. Radiol 2022; 302 (01) 84-87
  • 52 Mahajan S, Zhang F, Mahajan A, Zimnowodzki S. Parsonage Turner syndrome after COVID-19 vaccination. Muscle Nerve 2021; 64 (01) E3-E4
  • 53 Chua MMJ, Hayes MT, Cosgrove R. Parsonage-Turner syndrome following COVID-19 vaccination and review of the literature. Surg Neurol Int 2022; 13: 152
  • 54 Sharma R, Dua B, Goyal S, Tiwari T. Parsonage–Turner syndrome following COVID-19 vaccine. Ann Indian Acad Neurol 2022; 25 (05) 973-975
  • 55 Ghanta RB, Karistinos A, Atassi OH. Parsonage-Turner Syndrome After COVID-19 vaccination: a case report. JBJS Case Connect 2022;12(02):
  • 56 Castelli GP, Pognani C, Sozzi C, Franchini M, Vivona L. Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Crit Care 2021; 25 (01) 137
  • 57 Mehta PR, Apap Mangion S, Benger M. et al. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: a report of two UK cases. Brain Behav Immun 2021; 95: 514-517
  • 58 Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet 2021; 397 (10285): e11
  • 59 Kakovan M, Ghorbani Shirkouhi S, Zarei M, Andalib S. Stroke associated with COVID-19 vaccines. J Stroke Cerebrovasc Dis 2022; 31 (06) 106440
  • 60 Kolahchi Z, Khanmirzaei M, Mowla A. Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review. J Neurol Sci 2022; 439: 120327
  • 61 Vogrig A, Janes F, Gigli GL. et al. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clin Neurol Neurosurg 2021; 208: 106839
  • 62 Cao L, Ren L. Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. Acta Neurol Belg 2022; 122 (03) 793-795
  • 63 Ozgen Kenangil G, Ari BC, Guler C, Demir MK. Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine. Acta Neurol Belg 2021; 121 (04) 1089-1091
  • 64 Tahir N, Koorapati G, Prasad S. et al. SARS-CoV-2 vaccination-induced transverse myelitis. Cureus 2021; 13 (07) e16624
  • 65 Pagenkopf C, Südmeyer M. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol 2021; 358: 577606
  • 66 Havla J, Schultz Y, Zimmermann H, Hohlfeld R, Danek A, Kümpfel T. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol 2022; 269 (01) 55-58
  • 67 Chakrabarti SS, Tiwari A, Jaiswal S. et al. rapidly progressive dementia with asymmetric rigidity following ChAdOx1 nCoV-19 vaccination. Aging Dis 2022; 13 (03) 633-636
  • 68 Walter A, Kraemer M. A neurologist's rhombencephalitis after comirnaty vaccination. A change of perspective. Neurol Res Pract 2021; 3 (01) 56
  • 69 DeDent AM, Farrand E. Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax 2022; 77 (01) 9-10
  • 70 So C, Izumi S, Ishida A. et al. COVID-19 mRNA vaccine-related interstitial lung disease: two case reports and literature review. Respirol Case Rep 2022; 10 (04) e0938
  • 71 Bando T, Takei R, Mutoh Y. et al. Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination. Eur Respir J 2022; 59 (03) 2102806
  • 72 Graça LL, Amaral MJ, Serôdio M, Costa B. Extensive thrombosis after COVID-19 vaccine: cause or coincidence?. BMJ Case Rep 2021; 14 (08) e244878
  • 73 Leclerc S, Royal V, Lamarche C, Laurin L-P. Minimal change dis- ease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. Am J Kidney Dis 2021; 78 (04) 607-610
  • 74 Lodato F, Larocca A, D'Errico A, Cennamo V. An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: coincidence, autoimmunity or drug-related liver injury. J Hepatol 2021; 75 (05) 1254-1256
  • 75 Walter T, Connor S, Stedman C, Doogue M. A case of acute necrotising pancreatitis following the second dose of Pfizer-BioNTech COVID-19 mRNA vaccine. Br J Clin Pharmacol 2022; 88 (03) 1385-1386
  • 76 Parkash O, Sharko A, Farooqi A, Ying GW, Sura P. Acute pancreatitis: a possible side effect of COVID-19 vaccine. Cureus 2021; 13 (04) e14741
  • 77 Naranjo CA, Busto U, Sellers EM. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30 (02) 239-245
  • 78 Sharma A, Parekh SG. Musculoskeletal sequelae following COVID-19 mRNA vaccination. J Orthop Res 2022; 1 (03) 100044
  • 79 Wiesel BB, Keeling LE. Shoulder injury related to vaccine administration. J Am Acad Orthop Surg 2021; 29 (17) 732-739
  • 80 Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N. COVID-19 vaccine-related myositis. QJM 2021; 114 (06) 424-425
  • 81 Dawoud R, Haddad D, Shah V. et al. COVID-19 vaccine-related arthritis: a descriptive study of case reports on a rare complication. Cureus 2022; 14 (07) e26702
  • 82 Zhao Y, Wu X. Influence of COVID-19 vaccines on endocrine system. Endocrine 2022; 78 (02) 241-246
  • 83 Bennet WM, Elamin A, Newell-Price JD. Subacute thyroiditis following COVID-19 vaccination: case report and Society for Endocrinology survey. Clin Endocrinol (Oxf) 2023; 98 (03) 452-453
  • 84 Triantafyllidis KK, Giannos P, Stathi D, Kechagias KS. Graves' disease following vaccination against SARS-CoV-2: a systematic review of the reported cases. Front Endocrinol (Lausanne) 2022; 13: 938001
  • 85 Siolos A, Gartzonika K, Tigas S. Thyroiditis following vaccination against COVID-19: Report of two cases and review of the literature. Metab Open 2021; 12: 100136
  • 86 Murvelashvili N, Tessnow A. A case of hypophysitis following immunization with the mRNA-1273 SARS-CoV-2 vaccine. J Investig Med High Impact Case Rep 2021; 9: 23 247096211043386
  • 87 Graf A, Armeni E, Dickinson L. et al. Adrenal haemorrhage and infarction in the setting of vaccine-induced immune thrombocytopenia and thrombosis after SARS-CoV-2 (Oxford–AstraZeneca) vaccination. Endocrinol Diabetes Metab Case Rep 2022
  • 88 Taylor P, Allen L, Shrikrishnapalasuriyar N, Stechman M, Rees A. Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage. Clin Endocrinol (Oxf) 2022; 97 (01) 26-27
  • 89 Varona JF, García-Isidro M, Moeinvaziri M, Ramos-López M, Fernández-Domínguez M. Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Eur J Intern Med 2021; 91: 90-92
  • 90 Cohen D, Krauthammer SH, Wolf I, Even-Sapir E. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging 2021; 48 (06) 1854-1863
  • 91 Minamimoto R, Kiyomatsu T. Effects of COVID-19 vaccination on FDG-PET/CT imaging: a literature review. Glob Health Med 2021; 3 (03) 129-133
  • 92 Demmert TT, Maric I, Pomykala KL. et al. Novel 68Ga-FAPI PET/CT offers oncologic staging without COVID-19 vaccine-related pitfalls. J Nucl Med 2023; 64 (03) 368-371
  • 93 Kim E, Reig B. Breast inflammatory change is transient following COVID-19 vaccination. Radiology 2022; 304 (03) 533